HK95091A - Synergistic pharmaceutical compositions, their production and use - Google Patents

Synergistic pharmaceutical compositions, their production and use

Info

Publication number
HK95091A
HK95091A HK950/91A HK95091A HK95091A HK 95091 A HK95091 A HK 95091A HK 950/91 A HK950/91 A HK 950/91A HK 95091 A HK95091 A HK 95091A HK 95091 A HK95091 A HK 95091A
Authority
HK
Hong Kong
Prior art keywords
weight
deprenyl
phenylalanine
parts
benzerazide
Prior art date
Application number
HK950/91A
Other languages
German (de)
English (en)
French (fr)
Inventor
Jozsef Knoll
Walter Birkmayer
Katalin Kalloy
Jeno Marton
Zoltan Ecsery
Original Assignee
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. filed Critical Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Publication of HK95091A publication Critical patent/HK95091A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK950/91A 1983-12-20 1991-11-28 Synergistic pharmaceutical compositions, their production and use HK95091A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU834343A HU193662B (en) 1983-12-20 1983-12-20 Process for producing synergetic pharmaceutical composition of antidepressive aktivity

Publications (1)

Publication Number Publication Date
HK95091A true HK95091A (en) 1991-12-06

Family

ID=10967709

Family Applications (1)

Application Number Title Priority Date Filing Date
HK950/91A HK95091A (en) 1983-12-20 1991-11-28 Synergistic pharmaceutical compositions, their production and use

Country Status (10)

Country Link
US (1) US4880833A (da)
EP (1) EP0146363B1 (da)
JP (1) JPH0713014B2 (da)
BG (1) BG60400B2 (da)
DE (1) DE3475164D1 (da)
DK (1) DK161669C (da)
HK (1) HK95091A (da)
HU (1) HU193662B (da)
IE (1) IE57759B1 (da)
IL (1) IL73788A (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3764144D1 (de) * 1986-04-16 1990-09-13 Asta Pharma Ag Synergistische kombination von amantadin und selegilin.
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
US5561163A (en) * 1990-08-31 1996-10-01 Deprenyl Animal Health, Inc. Treating hearing loss with deprenyl
US5565495A (en) * 1990-08-31 1996-10-15 Deprenyl Animal Health, Inc. Method for survival curve shifting in dogs
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
SE9301112D0 (sv) * 1993-04-02 1993-04-02 Orion-Yhtymae Oy A new composition
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
US5455276A (en) * 1993-05-20 1995-10-03 Sabelli; Hector C. Method for treating depression
GB9426079D0 (en) * 1994-12-23 1995-02-22 Orion Yhtymae Oy A gelatine capsule
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
CA2223588C (en) * 1995-06-07 2004-01-06 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
EP1457534B1 (en) 2001-12-18 2008-08-27 Kiwa Chemical Industry Co., Ltd. Ink for inkjet recording
GB0313630D0 (en) * 2003-06-12 2003-07-16 Wwk Trust The Compositions for the enhanced treatment of depression
CN104788338A (zh) * 2014-10-17 2015-07-22 上海益生源药业有限公司 盐酸苄丝肼的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1210873B (de) * 1959-03-18 1966-02-17 Hoffmann La Roche Verfahren zur Herstellung von Halogenalkylaminen
US3362879A (en) * 1965-01-11 1968-01-09 Health Education Welfare Usa Tyrosine tranquilizing compositions and methods of treatment
US4156017A (en) * 1977-02-22 1979-05-22 Schering Aktiengesellschaft Pesticides
US4377595A (en) * 1979-08-13 1983-03-22 Massachusetts Institute Of Technology Process for reducing depression
US4355044A (en) * 1980-12-19 1982-10-19 Bernardo Heller D-Phenylalanine treatment
US4431670A (en) * 1980-12-19 1984-02-14 Bernardo Heller D-Phenylalanine treatment

Also Published As

Publication number Publication date
EP0146363A2 (en) 1985-06-26
DK612684A (da) 1985-06-21
JPS6110509A (ja) 1986-01-18
US4880833A (en) 1989-11-14
EP0146363A3 (en) 1985-07-24
EP0146363B1 (en) 1988-11-17
IL73788A (en) 1987-11-30
DK161669C (da) 1992-01-27
BG60400B2 (bg) 1995-02-28
HU193662B (en) 1987-11-30
HUT35517A (en) 1985-07-29
IE57759B1 (en) 1993-03-24
JPH0713014B2 (ja) 1995-02-15
DK161669B (da) 1991-08-05
DE3475164D1 (en) 1988-12-22
DK612684D0 (da) 1984-12-19
IE843149L (en) 1985-06-20
IL73788A0 (en) 1985-03-31

Similar Documents

Publication Publication Date Title
EP0146363B1 (en) Synergistic pharmaceutical compositions, their production and use
AU685510B2 (en) Potentiation of drug response
CA2312729C (en) Use of 9-deoxy-2', 9-.alpha.-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
US4590213A (en) Anti-anxiety method
CZ290691B6 (cs) Farmaceutický prostředek
KR102372194B1 (ko) Lsd1 억제제를 이용한 다발성 경화증의 치료방법
US10485790B1 (en) Salts of cycloserine compounds and applications thereof
JPH0393718A (ja) 早発射精治療剤
NZ246384A (en) Two phase pharmaceutical compositions comprising a monoamine oxidase inhibitor and an uptake inhibitor
US20260102392A1 (en) Prophylactic or therapeutic drug for neurodegenerative diseases
JPH11504000A (ja) 造血前駆細胞の増殖を促進するチオール類
JP2004534094A (ja) 二日酔いに有効な組成物及びそのための使用
EP3786158A1 (en) Cyclohexenyl compounds, compositions comprising them and uses thereof
US4331687A (en) Treatment of Parkinson's disease
US3462534A (en) Production of an antidepressant effect with esters of gallic acid
HU211305A9 (en) Novel method for treatment of parkinson's disease
CN117797134A (zh) 一种4-tmap治疗或缓解抑郁症的用途
HUP9903723A2 (hu) Ginkgolidok alkalmazása membráneszpresszió gátlására
HK1013797A (en) Potentiation of drug response by a serotonin 1a receptor antagonist
WO2019080383A1 (zh) 一种减肥降脂的组合物及其制备方法与用途
MXPA06004782A (es) Formulacion oral antidepresiva que comprende acido acetilsalicilico para acelerar la presentacion de la accion
HK40005336B (zh) 包含美金刚和褪黑素的组合的药物组合物

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)